BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong AM, Pozen A, Anastos K, Kelvin EA, Nash D. Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis. AIDS Patient Care STDS 2019;33:93-103. [PMID: 30844304 DOI: 10.1089/apc.2018.0190] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Denyer R, Zemskova J, Benator DA. HIV treatment with dolutegravir and doravirine: rationale for selection and clinical outcomes in a highly treatment experienced population. Int J STD AIDS. [DOI: 10.1177/09564624221116533] [Reference Citation Analysis]
2 Drwiega EN, Badowski ME, Michienzi S. Antiretroviral drug-drug interactions: A comparison of online drug interaction databases. J Clin Pharm Ther 2022. [PMID: 36059105 DOI: 10.1111/jcpt.13750] [Reference Citation Analysis]
3 Perello R, Losada A, Chen J, Supervia A, Salgado E, Smithson A, Xipell M, Inciarte A, Vallecillo G. Amphetamine-related intoxications in people living with HIV: An observational study in an emergency department in Barcelona (Spain) from 2018 to 2020. HIV Med 2022. [PMID: 35945158 DOI: 10.1111/hiv.13365] [Reference Citation Analysis]
4 Bade B, Gwin M, Triplette M, Wiener RS, Crothers K. Comorbidity and life expectancy in shared decision making for lung cancer screening. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.07.003] [Reference Citation Analysis]
5 Paudel M, Prajapati G, Buysman EK, Goswami S, Mao J, McNiff K, Kumar P. Comorbidity and comedication burden among people living with HIV in the United States. Curr Med Res Opin 2022;:1-13. [PMID: 35757905 DOI: 10.1080/03007995.2022.2088714] [Reference Citation Analysis]
6 Jackson L, Lee Y, Batey DS. Structural violence within communities and its impact on the well-being of people with HIV (PWH). AIDS Care 2022;:1-6. [PMID: 35727148 DOI: 10.1080/09540121.2022.2088679] [Reference Citation Analysis]
7 Mefford MT, Silverberg MJ, Leong TK, Hechter RC, Towner WJ, Go AS, Horberg M, Hu H, Harrison TN, Sung SH, Reynolds K. Multimorbidity Burden and Incident Heart Failure Among People With and Without HIV: The HIV-HEART Study. Mayo Clin Proc Innov Qual Outcomes 2022;6:218-27. [PMID: 35539894 DOI: 10.1016/j.mayocpiqo.2022.03.004] [Reference Citation Analysis]
8 Olivieri-Mui B, Wilson I, Shi S, Montano M, McCarthy EP, Oh G, Kim DH. Geriatric Conditions Associated with Nonadherence to Antiretroviral Therapy Among Older People with HIV: The Importance of Frailty. AIDS Patient Care STDS 2022;36:226-35. [PMID: 35687816 DOI: 10.1089/apc.2022.0040] [Reference Citation Analysis]
9 Emanuel KM, Runner K, Brodnik ZD, Morsey BM, Lamberty BG, Johnson HS, Acharya A, Byrareddy SN, España RA, Fox HS, Gaskill PJ. Deprenyl reduces inflammation during acute SIV infection. iScience 2022;25:104207. [PMID: 35494221 DOI: 10.1016/j.isci.2022.104207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Maggiolo F, Rizzardini G, Molina J, Pulido F, De Wit S, Vandekerckhove L, Berenguer J, D'antoni ML, Blair C, Chuck SK, Piontkowsky D, Martin H, Haubrich R, Mcnicholl IR, Gallant J. Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV : Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years of age. HIV Medicine. [DOI: 10.1111/hiv.13319] [Reference Citation Analysis]
11 Rubin LH, Neijna AG, Shi Q, Hoover DR, Tamraz B, Anastos K, Edmonds A, Fischl MA, Gustafson D, Maki PM, Merenstein D, Sheth AN, Springer G, Vance D, Weber KM, Sharma A. Degree of Polypharmacy and Cognitive Function in Older Women with HIV. AIDS Res Hum Retroviruses 2022. [PMID: 35357949 DOI: 10.1089/AID.2021.0231] [Reference Citation Analysis]
12 Nanditha NGA, Dong X, McLinden T, Sereda P, Kopec J, Hogg RS, Montaner JSG, Lima VD. The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada. BMC Med Res Methodol 2022;22:1. [PMID: 34991473 DOI: 10.1186/s12874-021-01448-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen Y, Anderson D, Pericone C, Donga P. Vol. 9, Issue 1, 2022 January 03, 2022 EDT Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors. JHEOR 2022. [DOI: 10.36469/jheor.2022.30184] [Reference Citation Analysis]
14 Alcaix D. Manifestaciones reumatológicas de la infección por el virus de la inmunodeficiencia humana. EMC - Aparato Locomotor 2021;54:1-15. [DOI: 10.1016/s1286-935x(21)45751-5] [Reference Citation Analysis]
15 Smith L, Letendre S, Erlandson KM, Ma Q, Ellis RJ, Farhadian SF. Polypharmacy in older adults with HIV infection: Effects on the brain. J Am Geriatr Soc 2021. [PMID: 34855982 DOI: 10.1111/jgs.17569] [Reference Citation Analysis]
16 Sok P, Seeman MV, Nisenbaum R, Watson J, Rourke SB, On Behalf Of The Pshp Team. Four-Year Trajectories of Health-Related Quality of Life in People Living with HIV: Impact of Unmet Basic Needs across Age Groups in Positive Spaces, Healthy Places. Int J Environ Res Public Health 2021;18:12256. [PMID: 34832010 DOI: 10.3390/ijerph182212256] [Reference Citation Analysis]
17 Justice AC, Gordon KS, Romero J, Edelman EJ, Garcia BJ, Jones P, Khoo S, Lo Re V 3rd, Rentsch CT, Tate JP, Tseng A, Womack J, Jacobson D. Polypharmacy-associated risk of hospitalisation among people ageing with and without HIV: an observational study. Lancet Healthy Longev 2021;2:e639-50. [PMID: 34870254 DOI: 10.1016/S2666-7568(21)00206-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
18 Rubtsova AA, Wingood G, Ofotokun I, Mehta CC, Gustafson D, Vance DE, Sharma A, Adimora AA, Holstad M. Psychosocial Mechanisms of Self-rated Successful Aging with HIV: A Structural Equation Model. AIDS Behav 2021;25:2875-85. [PMID: 34115265 DOI: 10.1007/s10461-021-03340-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Taramasso L, De Vito A, Ricci ED, Orofino G, Squillace N, Menzaghi B, Molteni C, Gulminetti R, De Socio GV, Pellicanò GF, Sarchi E, Celesia BM, Calza L, Rusconi S, Valsecchi L, Martinelli CV, Cascio A, Maggi P, Vichi F, Angioni G, Guadagnino G, Cenderello G, Dentone C, Bandera A, Falasca K, Bonfanti P, Di Biagio A, Madeddu G; Behalf of the CISAI Study Group. Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. AIDS Patient Care STDS 2021;35:342-53. [PMID: 34524918 DOI: 10.1089/apc.2021.0089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Siegler E, Moxley J, Mauer E, Glesby M. Cross-sectional study of correlates and prevalence of functional and high-risk multimorbidity in an academic HIV practice in New York City. BMJ Open 2021;11:e047199. [PMID: 34380723 DOI: 10.1136/bmjopen-2020-047199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yu X, Westra JR, Giordano TP, Berenson AB, Baillargeon JG, Kuo YF. Assessing comorbidities and survival in HIV-infected and uninfected matched Medicare enrollees. AIDS 2021;35:1667-75. [PMID: 34049353 DOI: 10.1097/QAD.0000000000002963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Livio F, Deutschmann E, Moffa G, Rrustemi F, Stader F, Elzi L, Braun DL, Calmy A, Hachfeld A, Cavassini M, Tarr PE, Wissel K, Battegay M, Marzolini C; Swiss HIV Cohort Study. Analysis of inappropriate prescribing in elderly patients of the Swiss HIV Cohort Study reveals gender inequity. J Antimicrob Chemother 2021;76:758-64. [PMID: 33279997 DOI: 10.1093/jac/dkaa505] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
23 Olaru ID, Ferrand RA, Chisenga M, Yeung S, Macrae B, Chonzi P, Stabler RA, Hopkins H, Mabey D, Masunda KPE, Kranzer K. Prevalence of ESBL-producing Escherichia coli in adults with and without HIV presenting with urinary tract infections to primary care clinics in Zimbabwe. JAC Antimicrob Resist 2021;3:dlab082. [PMID: 34223141 DOI: 10.1093/jacamr/dlab082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Edelman EJ, Rentsch CT, Justice AC. Polypharmacy in HIV: recent insights and future directions. Curr Opin HIV AIDS 2020;15:126-33. [PMID: 31833963 DOI: 10.1097/COH.0000000000000608] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 24.0] [Reference Citation Analysis]
25 Sangarlangkarn A, Zeuli JD, Avihingsanon A. Caring for Older People with HIV. Fundamentals of HIV Medicine 2021 2021. [DOI: 10.1093/med/9780197576595.003.0034] [Reference Citation Analysis]
26 Causey ST, Towe SL, Hartsock J, Xu Y, Meade CS. Perceived Healthcare Access among Persons with and without HIV Who Use Illicit Stimulants: The Role of Cumulative Risk. Subst Use Misuse 2021;56:1387-96. [PMID: 34034631 DOI: 10.1080/10826084.2021.1928211] [Reference Citation Analysis]
27 Siegler EL, Moxley JH, Glesby MJ. Aging-Related Concerns of People Living with HIV Referred for Geriatric Consultation. HIV AIDS (Auckl) 2021;13:467-74. [PMID: 33958897 DOI: 10.2147/HIV.S306532] [Reference Citation Analysis]
28 Frain J. Considering the Impact of Aging When Caring For and Treating Adults With HIV. J Gerontol Nurs 2020;46:31-40. [PMID: 32219455 DOI: 10.3928/00989134-20200304-02] [Reference Citation Analysis]
29 Olaru ID, Tacconelli E, Yeung S, Ferrand RA, Stabler RA, Hopkins H, Aiken AM, Kranzer K. The association between antimicrobial resistance and HIV infection: a systematic review and meta-analysis. Clin Microbiol Infect 2021;27:846-53. [PMID: 33813126 DOI: 10.1016/j.cmi.2021.03.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 López-Centeno B, Badenes-Olmedo C, Mataix-Sanjuan Á, McAllister K, Bellón JM, Gibbons S, Balsalobre P, Pérez-Latorre L, Benedí J, Marzolini C, Aranguren-Oyarzábal A, Khoo S, Calvo-Alcántara MJ, Berenguer J. Polypharmacy and Drug-Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study. Clin Infect Dis 2020;71:353-62. [PMID: 31428770 DOI: 10.1093/cid/ciz811] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 25.0] [Reference Citation Analysis]
31 Sun-Suslow N, Paolillo EW, Morgan EE, Letendre S, Iudicello J, Moore DJ. Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders. J Acquir Immune Defic Syndr 2020;84:522-6. [PMID: 32692111 DOI: 10.1097/QAI.0000000000002391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
32 Schexnayder J, Longenecker CT, Muiruri C, Bosworth HB, Gebhardt D, Gonzales SE, Hanson JE, Hileman CO, Okeke NL, Sico IP, Vedanthan R, Webel AR. Understanding constraints on integrated care for people with HIV and multimorbid cardiovascular conditions: an application of the Theoretical Domains Framework. Implement Sci Commun 2021;2:17. [PMID: 33579396 DOI: 10.1186/s43058-021-00114-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Tyrberg E, Edén A, Eriksen J, Nilsson S, Treutiger CJ, Thalme A, Mellgren Å, Gisslén M, Andersson LM. Higher plasma drug levels in elderly people living with HIV treated with darunavir. PLoS One 2021;16:e0246171. [PMID: 33539440 DOI: 10.1371/journal.pone.0246171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kumar RN, Masters MC, Williams J, Morrison LR, Galvin S, Krueger KM. Evaluation of Adherence to Dual-Energy X-Ray Absorptiometry Scan Ordering for Persons Living with HIV at a Tertiary Medical Center. AIDS Patient Care STDS 2021;35:31-2. [PMID: 33571045 DOI: 10.1089/apc.2020.0250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Nanditha NGA, Paiero A, Tafessu HM, St-Jean M, McLinden T, Justice AC, Kopec J, Montaner JSG, Hogg RS, Lima VD. Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study. BMJ Open 2021;11:e041734. [PMID: 33419911 DOI: 10.1136/bmjopen-2020-041734] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
36 Shiau S, Bender AA, O'Halloran JA, Sundermann E, Aggarwal J, Althoff KN, Baker JV, Deeks S, Fried LP, Karpiak S, Karris MY, Marcotte TD, Nachega JB, Margolick JB, Erlandson KM, Moore DJ. The Current State of HIV and Aging: Findings Presented at the 10th International Workshop on HIV and Aging. AIDS Res Hum Retroviruses 2020;36:973-81. [PMID: 32847368 DOI: 10.1089/AID.2020.0128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Turrini G, Chan SS, Klein PW, Cohen SM, Dempsey A, Hauck H, Cheever LW, Chappel AR. Assessing the health status and mortality of older people over 65 with HIV. PLoS One 2020;15:e0241833. [PMID: 33152053 DOI: 10.1371/journal.pone.0241833] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
38 Back D, Marzolini C. The challenge of HIV treatment in an era of polypharmacy. J Int AIDS Soc 2020;23:e25449. [PMID: 32011104 DOI: 10.1002/jia2.25449] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 28.0] [Reference Citation Analysis]
39 Lee Y, Walton R, Jackson L, Batey DS. Community-Level Factors and HIV Health Among Older People Living With HIV (PLWH) in Alabama, United States: A Qualitative Analysis. J Assoc Nurses AIDS Care 2020. [PMID: 33009174 DOI: 10.1097/JNC.0000000000000214] [Reference Citation Analysis]
40 Ruellan AL, Bourneau-Martin D, Joyau C, Secher S, Fialaire P, Hitoto H, Leautez S, Michau C, Vatan R, Billaud E, Briet M, Jolliet P, Raffi F, Allavena C. Assessment of drug-drug interaction in an elderly human immunodeficiency virus population: Comparison of 3 expert databases. Br J Clin Pharmacol 2021;87:1194-202. [PMID: 32696528 DOI: 10.1111/bcp.14491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 McMillan JM, Gill MJ, Power C, Fujiwara E, Hogan DB, Rubin LH. Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes. AIDS Patient Care STDS 2020;34:284-94. [PMID: 32639207 DOI: 10.1089/apc.2020.0051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
42 Del Carmen T, Johnston C, Burchett C, Siegler EL. Special Topics in the Care of Older People with HIV. Curr Treat Options Infect Dis 2019;11:388-400. [PMID: 33343235 DOI: 10.1007/s40506-019-00204-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ware D, Palella FJ , Jr, Chew KW, Friedman MR, D'Souza G, Ho K, Plankey M. Examination of Polypharmacy Trajectories Among HIV-Positive and HIV-Negative Men in an Ongoing Longitudinal Cohort from 2004 to 2016. AIDS Patient Care STDS 2019;33:354-65. [PMID: 31369298 DOI: 10.1089/apc.2019.0057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]